Semaglutide
A GLP-1 receptor agonist that improves glycemic control and reduces appetite.
Written by Anthivera EditorialPending medical review
Updated Regulatory status verified May 1, 2026
FDA-approved
Relevance for women
FDA-approved for weight management (Wegovy) and type 2 diabetes (Ozempic); widely prescribed via telehealth.
Featured in focus this week
Top weekly research-mention score (158) across 2 cite-worthy review(s).
Week of 2026-08-17 · research-driven pick
Recent research mentioning Semaglutide
Pulled from our weekly editorial digest of PubMed, FDA, NEJM, JAMA, and Endpoints — cite-worthy entries only.
Estimating Eligibility for GLP-1 Receptor Agonists for Chronic Weight Management and Cardiovascular Disease in Australia: Cross-Sectional Analysis of National Health Survey Data.
PubMed (women's-health + peptide query) · 2026 Aug · digested 2026-08-17
Semaglutide for Refractory Reactive Hypoglycaemia: A Case Report.
PubMed (women's-health + peptide query) · 2026 Jul · digested 2026-08-17
Real-World Use of Subsidised Semaglutide in Icelandic Children With Obesity: A Nationwide Retrospective Cohort Study.
PubMed (women's-health + peptide query) · 2026 Aug · digested 2026-08-03
Atypical Anorexia Nervosa Developed in a Patient with Severe Obesity and Type 2 Diabetes Following Sleeve Gastrectomy and Postoperative Treatment with Semaglutide and Tirzepatide.
PubMed (women's-health + peptide query) · 2026 Aug 1 · digested 2026-08-03
Semaglutide in Practice: Insights from a Retrospective Case Series at a Jharkhand Tertiary Care Hospital.
PubMed (women's-health + peptide query) · 2026 Jun · digested 2026-08-03
Where the evidence sits
Anthivera’s calibrated five-tier scale — what the strongest evidence on Semaglutide actually supports today.
- Preclinical
- Limited clinical
- Multiple human studies
- Phase 3
- FDA-approvedSemaglutide
FDA-approved: FDA-approved for the indication claimed.
Questions to bring to a consult
- 01What evidence is there for Semaglutide in women specifically — and does that include perimenopausal or postmenopausal cohorts?
- 02What is the current FDA regulatory status, and which compounding pharmacy will my prescription go through?
- 03What baseline labs do you require before starting, and how often do you monitor?
- 04What are the realistic timelines and what does “not working for you” look like in practice?
Providers that offer Semaglutide
- 4.5/5
Evergreen Women's Health
Strongest fit for perimenopausal women seeking continuity of care — pairs hormone testing with peptide protocols.
- 4.0/5
Canopy Telehealth Clinic
Broad catalog and broad geographic reach; longer intake process but thorough lab work.
See the full provider comparison for all peptides side by side.